Antibody-drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer. Qu F, Lu R, Liu Q, Wu X, et al. Cancer 2024 Jan 25. doi: 10.1002/cncr.35205.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Qu F, Lu R, Liu Q, Wu X, et al. Antibody-drug conjugates transform the outcome of individuals with low-HER2-expression advanced breast cancer. Cancer 2024 Jan 25. doi: 10.1002/cncr.35205.
PMID: 38271367